4th Quarter - Report

RAMPY NORTHRUP LLC for JOHNSON & JOHNSON SERVICES, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Legislation and regulations affecting medical devices, pharmaceuticals, cosmetics and other consumer products; Coronavirus impact and response; social determinants of health; policies impacting Medicare coverage and reimbursement for prescription drugs; MDUFA Reauthorization; PDUFA Reauthorization; H.R.6000, Cures 2.0 Act; H.R.5030/S.2706, DIVERSE Trials Act; H.R.5585, Advanced Research Project Agency-Health Act; S.3799, PREVENT Pandemics Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.

LobbyistCovered position, as disclosed
STEPHEN NORTHRUP —
STACEY RAMPY —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 4348 (117th), H.R. 7667 (117th), S. 3799 (117th), S. 2706 (117th), H.R. 2617 (117th), H.R. 5585 (117th), H.R. 5030 (117th), H.R. 6000 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.